Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients

Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients

Context: Critically ill patients has a large number of pathophysiological changes product of commitment and organ systems. Therefore, knowledge of the pharmacological properties of antimicrobials is essential to choose the best treatment. In order to optimize the response of antibiotic therapy and t...

Full description

Bibliographic Details
Main Authors:	Jorge S. Amador, Juan P. Carrasco, Álvaro A. Morales, Claudia P. Cortes
Format:	Article
Language:	English
Published:	GarVal Editorial Ltda. 2017-04-01
Series:	Journal of Pharmacy & Pharmacognosy Research
Subjects:	critically ill patients β-lactam antibiotics prolonged infusion
Online Access:	http://jppres.com/jppres/pdf/vol5/jppres16.157_5.2.88.pdf

Similar Items

Factors associated with the decision to administer β-lactams via prolonged infusion in patients with sepsis: a prospective observational cohort study
by: Yang Mao, et al.
Published: (2022-11-01)

Prolonged Infusion of β-Lactams Decreases Mortality in Patients with Septic Shock: A Retrospective before-and-after Study
by: Daniel Christoph Richter, et al.
Published: (2021-06-01)

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials
by: Van Arendonk Kyle J, et al.
Published: (2011-06-01)

Prolonged administration of β-lactam antibiotics – a comprehensive review and critical appraisal
by: Michael Osthoff, et al.
Published: (2016-10-01)

β-Lactam Antibiotics Renaissance
by: Wenling Qin, et al.
Published: (2014-05-01)

Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: A systematic review and meta-analysis
by: Laila Aboulatta, et al.
Published: (2020-09-01)

Current status of β-lactam antibiotic use and characterization of β-lactam-resistant Escherichia coli from commercial farms by integrated broiler chicken operations in Korea
by: Hye-Ri Jung, et al.
Published: (2023-12-01)

Suitability of Amoxicillin–Clavulanic Acid for Administration via Prolonged Infusion
by: Fawaz S, et al.
Published: (2020-01-01)

Extended Infusion of Beta-Lactams and Glycopeptides: A New Era in Pediatric Care? A Systematic Review and Meta-Analysis
by: Andrea Rahel Burch, et al.
Published: (2024-02-01)

Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against <em>Pseudomonas aeruginosa</em> to Clinical Settings
by: Iris K. Minichmayr, et al.
Published: (2022-08-01)

Activity of β-lactam antibiotics against certain microorganisms which cause mastitis in cows
by: Burmańczuk Artur, et al.
Published: (2016-09-01)

The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
by: Pengxiang Zhou, et al.
Published: (2022-10-01)

Erratum: The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
by: Frontiers Production Office
Published: (2022-12-01)

Prevalence of Streptococcus mitis in the bacterial plaques associated with gingivitis and its sensitivity to β-lactam antibiotics
by: M Azadeh, et al.
Published: (2010-01-01)

Self-resistance in Streptomyces, with Special Reference to β-Lactam Antibiotics
by: Hiroshi Ogawara
Published: (2016-05-01)

Extended infusion of β-lactams significantly reduces mortality and enhances microbiological eradication in paediatric patients: a systematic review and meta-analysisResearch in context
by: Kinga Anna Budai, et al.
Published: (2023-11-01)

Rapid Detection of Multiple Classes of β-Lactam Antibiotics in Blood Using an NDM-1 Biosensing Assay
by: Qinglai Meng, et al.
Published: (2021-09-01)

Could β-Lactam Antibiotics Block Humoral Immunity?
by: Cléa Melenotte, et al.
Published: (2021-09-01)

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients
by: Javier Martínez-Casanova, et al.
Published: (2023-03-01)

The biosynthesis of β-lactams
by: Goh, K, et al.
Published: (1993)

The state and consideration for skin test of β-lactam antibiotics in pediatrics
by: Chunhui Gao, et al.
Published: (2023-06-01)

Murepavadin induces envelope stress response and enhances the killing efficacies of β-lactam antibiotics by impairing the outer membrane integrity of Pseudomonas aeruginosa
by: Xiaoya Wei, et al.
Published: (2023-10-01)

Targeted Hydrolysis of β-Lactam Antibiotics in Dry Suspension Residue: A Proposed Method to Reduce Ecological Toxicity and Bacterial Resistance
by: Arne Brahms, et al.
Published: (2021-08-01)

β-lactam precision dosing in critically ill children: Current state and knowledge gaps
by: Sonya Tang Girdwood, et al.
Published: (2022-12-01)

Pitfalls in the Immunochemical Determination of β-Lactam Antibiotics in Water
by: Alexander Ecke, et al.
Published: (2021-03-01)

Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients
by: Milan Kaska, et al.
Published: (2018-09-01)

Is There Emergence of β-Lactam Antibiotic-Resistant Streptococcus pyogenes in China?
by: Yu D, et al.
Published: (2020-07-01)

The Pharmacokinetics of Beta-Lactam Antibiotics Using Scavenged Samples in Pediatric Intensive Care Patients: The EXPAT Kids Study Protocol
by: Stef Schouwenburg, et al.
Published: (2021-12-01)

Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’
by: Sofie A. M. Dhaese, et al.
Published: (2022-07-01)

Population dynamics of cross-protection against β-lactam antibiotics in droplet microreactors
by: Xinne Zhao, et al.
Published: (2023-12-01)

Molecular docking and proteomics reveals the synergistic antibacterial mechanism of theaflavin with β-lactam antibiotics against MRSA
by: Shuhan Guan, et al.
Published: (2022-11-01)

The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition
by: Jonathan Turner, et al.
Published: (2022-03-01)

Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action
by: Khalid M. Dousa, et al.
Published: (2022-02-01)

Optical microscopy reveals the dynamic nature of B. pseudomallei morphology during β-lactam antimicrobial susceptibility testing
by: Heather P. McLaughlin, et al.
Published: (2020-07-01)

Insights into the Effects and Mechanism of Andrographolide-Mediated Recovery of Susceptibility of Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics
by: Qiang Ma, et al.
Published: (2023-02-01)

Construction of an Electrochemical Receptor Sensor Based on Graphene/Thionine for the Sensitive Determination of β-Lactam Antibiotics Content in Milk
by: Lei Wang, et al.
Published: (2020-05-01)

Molecular Targets of β-Lactam-Based Antimicrobials: Beyond the Usual Suspects
by: Monika I. Konaklieva
Published: (2014-04-01)

β-Lactam Resistance in ESKAPE Pathogens Mediated Through Modifications in Penicillin-Binding Proteins: An Overview
by: Dhiviya Prabaa Muthuirulandi Sethuvel, et al.
Published: (2023-03-01)

The Importance of Porins and β-Lactamase in Outer Membrane Vesicles on the Hydrolysis of β-Lactam Antibiotics
by: Si Won Kim, et al.
Published: (2020-04-01)

Strategies to Improve the Biosynthesis of β-Lactam Antibiotics by Penicillin G Acylase: Progress and Prospects
by: Xin Pan, et al.
Published: (2022-07-01)